Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Fluorometholone

Known as: Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-6-methyl-, (6alpha,11beta)-, Fluorometholon, Fluorometolona 
A synthetic glucocorticoid with anti-inflammatory and anti-allergic properties. Fluorometholone exerts its effects by interacting with cytoplasmic… Expand
National Institutes of Health

Related topics

Related topics

33 relations

Broader (3)

Anti-Allergic AgentsAnti-Inflammatory AgentsGlucocorticoids
Corneal DiseasesDrug AllergyFLUOROMETHOLONE ACETATE 1 MG/ML Ophthalmic Suspension [Flarex]Fluorometholone 0.001 MG/MG Ophthalmic Ointment
Expand

Narrower (10)

CortisdinEfflumidexFLUOROMETHOLONE ACETATEFML
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Topical Fluorometholone Protects the Ocular Surface of Dry Eye Patients from Desiccating Stress: A Randomized Controlled Clinical Trial.
PURPOSE To assess the efficacy of topical 0.1% fluorometholone in dry eye disease (DED) patients for ameliorating the worsening… Expand
Highly Cited
2014
Highly Cited
2014
Randomized Comparison of Topical Prednisolone Acetate 1% Versus Fluorometholone 0.1% in the First Year After Descemet Membrane Endothelial Keratoplasty
Purpose: The aim of this study was to compare the efficacy and side effects of prednisolone acetate 1% versus fluorometholone 0.1… Expand
Review
2013
Review
2013
Intraocular Pressure Effects of Common Topical Steroids for Post-Cataract Inflammation: Are They All the Same?
The efficacy of topical corticosteroids as ocular anti-inflammatory agents following cataract surgery is well-documented. They… Expand
  • figure 1
  • figure 2
  • table 2
Review
2009
Review
2009
NCCN Task Force Report: Management of dermatologic and other toxicities associated with EGFR inhibition in patients with cancer.
This NCCN Task Force Report describes the management of dermatologic and ocular toxicities that occur in patients treated with… Expand
2008
2008
Treatment of recurrent corneal erosion syndrome using the combination of oral doxycycline and topical corticosteroid
Recurrent corneal erosion syndrome is a debilitating condition for which there are many treatment options with varying rates of… Expand
Highly Cited
2005
Highly Cited
2005
Functional outcomes and patient satisfaction after laser in situ keratomileusis for correction of myopia
PURPOSE: To determine subjective patient satisfaction and self‐perceived quality of vision after laser in situ keratomileusis… Expand
  • table 1
  • table 2
  • table 4
  • table 3
  • table 7
Review
2001
Review
2001
Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids.
PURPOSE To review the efficacy of inhibitors of matrix metalloproteinase-9, corticosteroids, and doxycycline for treatment of… Expand
Highly Cited
2000
Highly Cited
2000
Comparison of diclofenac and fluorometholone in preventing cystoid macular edema after small incision cataract surgery: a multicentered prospective trial.
PURPOSE To compare a nonsteroidal topical solution (0.1% diclofenac) to a steroidal topical solution (0.1% fluorometholone) in… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
1994
Highly Cited
1994
193-nm excimer photorefractive keratectomy in high myopia.
PURPOSE To evaluate the refractive results of 193-nm excimer laser photorefractive keratectomy (PRK) performed on 48 highly… Expand
Highly Cited
1975
Highly Cited
1975
Vehicle effects on ocular drug bioavailability i: evaluation of fluorometholone.
The influences of drug concentration and vehicle composition on the corneal penetration of the steroid fluorometholone were… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE